Medicure Inc. Appoints Vice President Of Research And Development

Medicure Inc. (TSX: MPH)(AMEX: MCU), a cardiovascular drug discovery and development company, today announced that Charles Gluchowski, PhD., has been appointed as the Company's Vice President of Research and Development. Dr. Gluchowski has held executive and senior scientific positions with several established and start-up life sciences companies including; Allergan, Inc., Synaptic Pharmaceutical Corp. (now part of Lundbeck), RiboGene, Questcor Pharmaceuticals, Inc., Ceretek, LLC, and most recently CTI Molecular Imaging (now part of Siemens). He joins Medicure from Life/Science Innovations, LLC, a professional advisory firm that he founded.